Spirepoint Private Client’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$524K Sell
7,414
-732
-9% -$54.8K 0.05% 181
2025
Q4
$643K Sell
8,146
-520
-6% -$41.2K 0.06% 149
2025
Q3
$714K Sell
8,666
-571
-6% -$44.9K 0.08% 143
2025
Q2
$743K Buy
9,237
+306
+3% +$23.6K 0.08% 127
2025
Q1
$717K Sell
8,931
-692
-7% -$57.6K 0.09% 109
2024
Q4
$788K Sell
9,623
-414
-4% -$34.4K 0.1% 112
2024
Q3
$828K Sell
10,037
-93
-0.9% -$6.95K 0.11% 112
2024
Q2
$711K Sell
10,130
-1,214
-11% -$86.7K 0.1% 115
2024
Q1
$841K Buy
+11,344
New +$791K 0.13% 98

Other funds holding MET

Spirepoint Private Client's MET Position: Q1 2026 in Review

Spirepoint Private Client reduced its MetLife (MET) stake by 9% in Q1 2026, selling an estimated $54.8K and leaving 7,414 shares worth $524K. The position accounts for 0.05% of the portfolio, ranked #181.

Spirepoint Private Client first reported a position in MET in Q1 2024 and has held it in 9 quarters since. The position peaked at $841K in Q1 2024. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • Spirepoint Private Client held 7,414 shares of MetLife worth $524K as of Q1 2026.
  • Spirepoint Private Client sold 732 MetLife shares in Q1 2026, an estimated $54.8K.
  • MetLife made up 0.05% of Spirepoint Private Client's portfolio in Q1 2026, its #181 holding.
  • Spirepoint Private Client first reported a position in MetLife in Q1 2024 and has held it in 9 quarters since.
  • Spirepoint Private Client's MetLife position peaked at $841K in Q1 2024.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Spirepoint Private Client's 13F filing for Q1 2026, filed 22 Apr 2026.